CONTEXT: Despite numerous benefits of live donor kidney transplant (LDKT), patient-level barriers often prevent African Americans from considering LDKT. Educational interventions designed to address patient-level barriers may increase willingness among African American patients with end-stage renal disease to explore LDKT as a treatment option. OBJECTIVE: To assess the effectiveness of a culturally sensitive educational intervention called Living ACTS (About Choices in Transplantation and Sharing) that was designed to address patient-level barriers to LDKT among African American patients with end-stage renal disease. DESIGN/PARTICIPANTS: Patients were randomized to intervention (n = 136) or control (n = 132) groups. They completed baseline measures and then viewed either the Living ACTS or control video. Both groups then completed an immediate follow-up measure and a 6-month assessment administered via telephone. MAIN OUTCOME MEASURES: Self-reported knowledge about LDKT, willingness to talk to the patient's family about LDKT, and perceived benefits of LDKT were measured at 3 time points. RESULTS: At 6-month follow-up, intervention participants demonstrated a significantly greater increase in knowledge of LDKT than control participants (F2,229=3.08, P= .05). Intervention participants expressed greater willingness to talk to patients' families about LDKT than did control participants from baseline through 6-month follow-up (F1,230 = 7.11, P= .008). Finally, at immediate follow-up, intervention participants reported greater endorsement of the benefits of LDKT than did control participants (F2,223 = 14.27, P< .001); however, this effect had disappeared by the 6-month follow-up. CONCLUSIONS: Living ACTS is effective at increasing and maintaining knowledge about LDKT among African American patients with end-stage renal disease who are considering transplant.
RCT Entities:
CONTEXT: Despite numerous benefits of live donor kidney transplant (LDKT), patient-level barriers often prevent African Americans from considering LDKT. Educational interventions designed to address patient-level barriers may increase willingness among African American patients with end-stage renal disease to explore LDKT as a treatment option. OBJECTIVE: To assess the effectiveness of a culturally sensitive educational intervention called Living ACTS (About Choices in Transplantation and Sharing) that was designed to address patient-level barriers to LDKT among African American patients with end-stage renal disease. DESIGN/PARTICIPANTS: Patients were randomized to intervention (n = 136) or control (n = 132) groups. They completed baseline measures and then viewed either the Living ACTS or control video. Both groups then completed an immediate follow-up measure and a 6-month assessment administered via telephone. MAIN OUTCOME MEASURES: Self-reported knowledge about LDKT, willingness to talk to the patient's family about LDKT, and perceived benefits of LDKT were measured at 3 time points. RESULTS: At 6-month follow-up, intervention participants demonstrated a significantly greater increase in knowledge of LDKT than control participants (F2,229=3.08, P= .05). Intervention participants expressed greater willingness to talk to patients' families about LDKT than did control participants from baseline through 6-month follow-up (F1,230 = 7.11, P= .008). Finally, at immediate follow-up, intervention participants reported greater endorsement of the benefits of LDKT than did control participants (F2,223 = 14.27, P< .001); however, this effect had disappeared by the 6-month follow-up. CONCLUSIONS: Living ACTS is effective at increasing and maintaining knowledge about LDKT among African American patients with end-stage renal disease who are considering transplant.
Authors: Komal Kumar; James M Tonascia; Abimereki D Muzaale; Tanjala S Purnell; Shane E Ottmann; Fawaz Al Ammary; Mary G Bowring; Anna Poon; Elizabeth A King; Allan B Massie; Eric K H Chow; Alvin G Thomas; Hao Ying; Marvin Borja; Jonathan M Konel; Macey Henderson; Andrew M Cameron; Jacqueline M Garonzik-Wang; Dorry L Segev Journal: Clin Transplant Date: 2018-06-15 Impact factor: 2.863
Authors: Rachel E Patzer; Sudeshna Paul; Laura Plantinga; Jennifer Gander; Leighann Sauls; Jenna Krisher; Laura L Mulloy; Eric M Gibney; Teri Browne; Carlos F Zayas; William M McClellan; Kimberly Jacob Arriola; Stephen O Pastan Journal: J Am Soc Nephrol Date: 2016-10-13 Impact factor: 10.121
Authors: Tanjala S Purnell; Xun Luo; Lisa A Cooper; Allan B Massie; Lauren M Kucirka; Macey L Henderson; Elisa J Gordon; Deidra C Crews; L Ebony Boulware; Dorry L Segev Journal: JAMA Date: 2018-01-02 Impact factor: 56.272
Authors: Akilah King; Fanny Y Lopez; Lydia Lissanu; Eric Robinson; Erik Almazan; Gabrielle Metoyer; Jacob Tanumihardjo; Michael Quinn; Monica Peek; Milda Saunders Journal: J Ren Care Date: 2020-01-09
Authors: Amy D Waterman; Marie Morgievich; David J Cohen; Zeeshan Butt; Harini A Chakkera; Carrie Lindower; Rebecca E Hays; Janet M Hiller; Krista L Lentine; Arthur J Matas; Emilio D Poggio; Michael A Rees; James R Rodrigue; Dianne LaPointe Rudow Journal: Clin J Am Soc Nephrol Date: 2015-06-26 Impact factor: 8.237
Authors: Mohua Basu; Lisa Petgrave-Nelson; Kayla D Smith; Jennie P Perryman; Kevin Clark; Stephen O Pastan; Thomas C Pearson; Christian P Larsen; Sudeshna Paul; Rachel E Patzer Journal: Clin J Am Soc Nephrol Date: 2018-03-26 Impact factor: 8.237
Authors: Heather F Hunt; James R Rodrigue; Mary Amanda Dew; Randolph L Schaffer; Macey L Henderson; Randee Bloom; Patrick Kacani; Pono Shim; Lee Bolton; William Sanchez; Krista L Lentine Journal: Curr Transplant Rep Date: 2018-02-05
Authors: Rhiannon D Reed; Deirdre Sawinski; Brittany A Shelton; Paul A MacLennan; Michael Hanaway; Vineeta Kumar; Dustin Long; Robert S Gaston; Meredith L Kilgore; Bruce A Julian; Cora E Lewis; Jayme E Locke Journal: Transplantation Date: 2018-12 Impact factor: 4.939
Authors: Amy D Waterman; Devika Nair; Intan Purnajo; Kerri L Cavanaugh; Brian S Mittman; John Devin Peipert Journal: Clin J Am Soc Nephrol Date: 2022-03-24 Impact factor: 8.237